A functions in sex determination in Drosophila [4, 5] , in maternal-to-zygotic transition and haematopoietic stem cell specification during zebrafish embryogenesis [6, 7] , in mouse spermatogenesis [8] [9] [10] , and in mouse brain development [11] . We recently discovered that lineage-specific deletion of the m 6 A 'writer' enzyme MET-TL3 in CD4
+ T cells (Mettl3
; CD4-Cre) led to disruption of naïve T cell homeostasis [12] . CD4
+ regulatory T cells (Tregs) comprise a critical subset of effector T cells, which are involved in resolution of inflammation and immunosuppression in tumor microenvironments [13] . However, the potential roles of m 6 A mRNA modification in Treg functions in vivo are unknown.
Mettl3 f/f ; CD4-Cre mice were normal without obvious defects during the first three months after birth. However, at the age of three months and older, the Mettl3 f/f ; CD4-Cre mice developed chronic inflammation in the intestine, evidenced by increased lymphocyte infiltration of the colon in Haematoxylin and eosin (H&E) staining analysis (Supplementary information, Figure S1 ). We hypothesized that the regulatory T cells might have lost their repressive functions in Mettl3 f/f ; CD4-Cre knockout mice. Therefore, we crossed Mettl3 f/f mice with Foxp3Cre-YFP mice to specifically delete Mettl3 and consequently the m 6 A RNA modification in regulatory T cells. Because the Foxp3Cre-YFP transgene is on the X chromosome, we analyzed only male mice for all the following experiments in comparison to WT littermate controls. The Mettl3 f/f ; Foxp3Cre mice developed severe autoimmune diseases (for both male and female mice) and thus were infertile. Strikingly, the Mettl3 f/f ; Foxp3Cre mice had substantially larger peripheral lymph nodes and spleen, developed alopecia and severe systemic autoimmune disease after weaning, and started to die in 8~9 weeks, indicating a systematic loss of suppressive function of Tregs without m 6 A RNA modification ( Figure 1A) . To explore the cellular mechanisms of the severe autoimmunity of Mettl3 f/f ; Foxp3Cre mice, we analyzed T cell effector cytokines in spleen and peripheral lymph nodes. The inflammatory Th1 and Th17 responses in Mettl3 f/f ; Foxp3Cre were at basal levels 10 days after birth, and were still under control before weaning (day 20), but became significantly elevated compared to WT at day 60, which was consistent with the observed autoimmune phenotypes ( Figure 1B ; CD4-Cre naïve T cells to Tregs was similar to littermate WT naïve T cells [12] , these results suggest a potential role for m 6 A in Treg function.
We surmise that Mettl3 -/-Tregs lost their suppressive function over the effector T cells. To test this hypothesis, we first set up an in vivo co-suppression assay by co-transferring naïve T cells without Treg cells, or with WT Tregs, or with Mettl3 -/-Tregs in different ratios into TCRβ -/-mice. The results showed that Mettl3 -/-Tregs completely lost the ability to suppress naïve T cell in vivo proliferation comparing to WT Tregs ( Figure 1D and Supplementary information, Figure S5 ). Second, we also performed the standard in vitro suppression assay by mixing Tregs isolated from Mettl3 f/f ; Foxp3Cre mice or WT littermate control mice with WT naïve T cells labeled by CellTrace at different ratios. We measured the cell proliferation by FACS at day 4 after co-culture, and the results showed that naïve T cells co-cultured with m 6 A KO Tregs proliferated much faster ( Figure 1E ). These data confirmed that Mettl3 -/-Tregs was evident at the very early age of one week, and further increased by four weeks of age ( Figure 1F ). RT-qPCR analysis confirmed the increase of Socs family mRNA levels without changes in levels of transcripts of other genes in the IL-2-STAT5 pathway (Supplementary information, Figure  S6 ). Furthermore, we applied m
6
A irCLIP-Seq, a newly developed and sensitive method to map m 6 A modification at near nucleotide resolution, in CD4 + T cells. We confirmed that m 6 A modification was enriched at 3′ UTR and 5′ UTR regions, with a consensus sequence of GG/ AACA/U ( Figure 1G ). In addition, Socs gene mRNAs, including Socs3 and Cish, were indeed modified by m 6 A ( Figure 1G) . We have previously shown that these Socs gene mRNAs are m 6 A targets in CD4 + T cells, and deletion of Mettl3 led to a global decrease of mRNA m 6 A levels and loss of m 6 A modification in specific Socs gene transcripts. Decreased m 6 A modification led to enhanced Socs mRNA stability, increased levels of SOCS proteins, and blockage in cytokine signal transduction [12] .
The IL2-STAT5 signaling axis is critical for Treg function [13] . The increased Socs function in Tregs in Mettl3 f/f ; Foxp3Cre mice is likely to inhibit the IL2-STAT5 pathway, similar to the scenario that depletion of m 6 A leads to increased Socs mRNAs and inhibition of IL7-STAT5 signaling in CD4 + naïve T cells [12] . To test this 
hypothesis, we FACS-sorted YFP+ Tregs from Mettl3
f/f ; Foxp3Cre-YFP mice and Foxp3Cre-YFP control mice, and stimulated these cells in vitro with IL-2. 15 minutes after stimulation, we applied the cell lysates to the phospho-kinase array to interrogate multiple signaling pathways. As shown in Figure 1H , phosphorylation of STAT5A and STAT5B decreased in Mettl3 KO Tregs comparing to WT Tregs (Quantification shown in Supplementary information, Figure S7 ). Western blots confirmed that the phosphorylation levels of STAT5 in m 6 A KO Tregs were severely diminished comparing to those in littermate control WT cells isolated from 6-weekold mice ( Figure 1I ). Taken together, we conclude that depletion of Mettl3/m 6 A in Tregs leads to increased Socs mRNA levels, thus suppresses the IL-2-STAT5 signaling pathway which is essential to Treg functions and stability.
We reported in our previous work that m 6 A controlled the rapid degradation of transcripts of early inducible genes in naïve T cells, and here again we observed similar elevated Socs mRNA levels in Mettl3 f/f ; Foxp3Cre Tregs. But in the latter case of Tregs, elevated Socs function targeted the IL-2-STAT5 signaling pathway, which critically controls Treg cell functions. Our results show that the m 6 A RNA modification specifically targets the same class of genes encoding components of essential signaling pathways in different T cell subtypes, thereby controlling the differentiation of naïve T cells [12] and also sustaining the suppressive functions of Tregs. Since Tregs in the tumor microenvironment suppress the tumor-killing functions of CD8 T cells, it is possible that selective depletion of m 6 A in tumor-infiltrated Tregs may be beneficial in combination with other forms of cancer immunotherapy.
